HEADER HYDROLASE 14-OCT-12 2YNF TITLE HIV-1 REVERSE TRANSCRIPTASE Y188L MUTANT IN COMPLEX WITH INHIBITOR TITLE 2 GSK560 COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EXORIBONUCLEASE H, P66 RT; COMPND 5 EC: 2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: P51 RT; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RESIDUES 588-1015; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HIV-1 M\:B_HXB2R; SOURCE 3 ORGANISM_COMMON: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HXB2 ISOLATE); SOURCE 4 ORGANISM_TAXID: 11706; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PKK233-2 VARIANT; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HIV-1 M\:B_HXB2R; SOURCE 12 ORGANISM_COMMON: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HXB2 ISOLATE); SOURCE 13 ORGANISM_TAXID: 11706; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PKK233-2 VARIANT KEYWDS HYDROLASE, NNRTI EXPDTA X-RAY DIFFRACTION AUTHOR P.CHONG,P.SEBAHAR,M.YOUNGMAN,D.GARRIDO,H.ZHANG,E.L.STEWART,R.T.NOLTE, AUTHOR 2 L.WANG,R.G.FERRIS,M.EDELSTEIN,K.WEAVER,A.MATHIS,A.PEAT REVDAT 2 20-DEC-23 2YNF 1 REMARK LINK REVDAT 1 09-JAN-13 2YNF 0 JRNL AUTH P.CHONG,P.SEBAHAR,M.YOUNGMAN,D.GARRIDO,H.ZHANG,E.L.STEWART, JRNL AUTH 2 R.T.NOLTE,L.WANG,R.G.FERRIS,M.EDELSTEIN,K.WEAVER,A.MATHIS, JRNL AUTH 3 A.PEAT JRNL TITL RATIONAL DESIGN OF POTENT NON-NUCLEOSIDE INHIBITORS OF HIV-1 JRNL TITL 2 REVERSE TRANSCRIPTASE. JRNL REF J.MED.CHEM. V. 55 10601 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 23137340 JRNL DOI 10.1021/JM301294G REMARK 2 REMARK 2 RESOLUTION. 2.36 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.36 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 57009 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1783 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.36 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.43 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3302 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.60 REMARK 3 BIN R VALUE (WORKING SET) : 0.2310 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7728 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 434 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.27000 REMARK 3 B22 (A**2) : 0.31000 REMARK 3 B33 (A**2) : -0.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.277 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.216 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.154 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.266 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.902 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8008 ; 0.011 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 5441 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10920 ; 1.354 ; 1.962 REMARK 3 BOND ANGLES OTHERS (DEGREES): 13362 ; 0.850 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 966 ; 5.924 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 342 ;37.772 ;25.029 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1379 ;15.108 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 29 ;19.948 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1201 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8717 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1540 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 11 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A -1 A 155 REMARK 3 ORIGIN FOR THE GROUP (A): -29.6490 62.5300 41.8390 REMARK 3 T TENSOR REMARK 3 T11: 0.3251 T22: 0.2260 REMARK 3 T33: 0.1995 T12: 0.1076 REMARK 3 T13: -0.0073 T23: -0.0341 REMARK 3 L TENSOR REMARK 3 L11: 1.0446 L22: 1.7042 REMARK 3 L33: 3.2116 L12: -0.7011 REMARK 3 L13: -1.5695 L23: 1.8763 REMARK 3 S TENSOR REMARK 3 S11: 0.1629 S12: 0.1103 S13: 0.0037 REMARK 3 S21: 0.1853 S22: -0.3116 S23: -0.0053 REMARK 3 S31: -0.1155 S32: -0.3630 S33: 0.1488 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 156 A 253 REMARK 3 ORIGIN FOR THE GROUP (A): -14.3650 67.2400 21.4080 REMARK 3 T TENSOR REMARK 3 T11: 0.6597 T22: 0.2553 REMARK 3 T33: 0.8376 T12: 0.2253 REMARK 3 T13: 0.2735 T23: 0.0037 REMARK 3 L TENSOR REMARK 3 L11: 5.3652 L22: 2.4962 REMARK 3 L33: 2.3222 L12: -1.9270 REMARK 3 L13: -3.2781 L23: 1.8704 REMARK 3 S TENSOR REMARK 3 S11: 0.9287 S12: 0.2371 S13: 1.4203 REMARK 3 S21: -0.5960 S22: 0.0475 S23: -0.9452 REMARK 3 S31: -0.8054 S32: -0.1909 S33: -0.9761 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 254 A 325 REMARK 3 ORIGIN FOR THE GROUP (A): 8.7440 51.1110 30.1060 REMARK 3 T TENSOR REMARK 3 T11: 0.1436 T22: 0.2987 REMARK 3 T33: 0.4397 T12: -0.0388 REMARK 3 T13: -0.0120 T23: -0.1706 REMARK 3 L TENSOR REMARK 3 L11: 3.1755 L22: 1.9231 REMARK 3 L33: 6.8639 L12: -1.4906 REMARK 3 L13: 2.5907 L23: -0.8296 REMARK 3 S TENSOR REMARK 3 S11: 0.1396 S12: -0.3399 S13: 0.3647 REMARK 3 S21: 0.0747 S22: 0.2633 S23: -0.5859 REMARK 3 S31: -0.0472 S32: 0.2992 S33: -0.4029 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 326 A 363 REMARK 3 ORIGIN FOR THE GROUP (A): 6.0760 43.6760 17.9150 REMARK 3 T TENSOR REMARK 3 T11: 0.2063 T22: 0.2171 REMARK 3 T33: 0.3212 T12: 0.0062 REMARK 3 T13: 0.0654 T23: 0.0055 REMARK 3 L TENSOR REMARK 3 L11: 1.8543 L22: 7.1985 REMARK 3 L33: 1.6639 L12: -2.1362 REMARK 3 L13: -0.5897 L23: -1.2110 REMARK 3 S TENSOR REMARK 3 S11: 0.0171 S12: -0.1434 S13: 0.1477 REMARK 3 S21: 0.3866 S22: -0.0218 S23: -0.4639 REMARK 3 S31: -0.1995 S32: 0.1883 S33: 0.0047 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 364 A 527 REMARK 3 ORIGIN FOR THE GROUP (A): 10.1670 21.5520 21.8860 REMARK 3 T TENSOR REMARK 3 T11: 0.1932 T22: 0.2859 REMARK 3 T33: 0.2708 T12: 0.0876 REMARK 3 T13: 0.0251 T23: 0.0278 REMARK 3 L TENSOR REMARK 3 L11: 0.5299 L22: 2.4368 REMARK 3 L33: 1.5025 L12: -0.7497 REMARK 3 L13: 0.3473 L23: -1.2795 REMARK 3 S TENSOR REMARK 3 S11: 0.0931 S12: -0.0465 S13: 0.1772 REMARK 3 S21: -0.1250 S22: -0.1606 S23: -0.3337 REMARK 3 S31: 0.1679 S32: 0.2766 S33: 0.0674 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 528 A 558 REMARK 3 ORIGIN FOR THE GROUP (A): 10.3870 2.9000 28.7070 REMARK 3 T TENSOR REMARK 3 T11: 0.5663 T22: 0.2370 REMARK 3 T33: 0.2340 T12: 0.1636 REMARK 3 T13: -0.0478 T23: 0.0492 REMARK 3 L TENSOR REMARK 3 L11: 5.3238 L22: 2.5251 REMARK 3 L33: 3.7680 L12: -0.0197 REMARK 3 L13: 2.2784 L23: -0.4258 REMARK 3 S TENSOR REMARK 3 S11: 0.3733 S12: -0.2751 S13: -0.3551 REMARK 3 S21: -0.4403 S22: -0.0168 S23: -0.0248 REMARK 3 S31: 1.1342 S32: -0.1476 S33: -0.3566 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 5 B 89 REMARK 3 ORIGIN FOR THE GROUP (A): -28.3580 39.3230 16.2670 REMARK 3 T TENSOR REMARK 3 T11: 0.1837 T22: 0.2572 REMARK 3 T33: 0.1619 T12: 0.0868 REMARK 3 T13: -0.0247 T23: -0.0673 REMARK 3 L TENSOR REMARK 3 L11: 3.3411 L22: 3.9784 REMARK 3 L33: 2.9367 L12: 1.3385 REMARK 3 L13: -0.7276 L23: 0.0298 REMARK 3 S TENSOR REMARK 3 S11: 0.0671 S12: -0.0304 S13: 0.0082 REMARK 3 S21: -0.0811 S22: -0.2221 S23: 0.0176 REMARK 3 S31: -0.0237 S32: -0.1178 S33: 0.1550 REMARK 3 REMARK 3 TLS GROUP : 8 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 90 B 194 REMARK 3 ORIGIN FOR THE GROUP (A): -36.2330 28.4890 10.5090 REMARK 3 T TENSOR REMARK 3 T11: 0.2340 T22: 0.2836 REMARK 3 T33: 0.2248 T12: 0.0387 REMARK 3 T13: -0.0400 T23: -0.0117 REMARK 3 L TENSOR REMARK 3 L11: 0.7283 L22: 2.3772 REMARK 3 L33: 1.4507 L12: 0.7357 REMARK 3 L13: 0.6622 L23: 1.1083 REMARK 3 S TENSOR REMARK 3 S11: 0.0757 S12: -0.1639 S13: 0.1247 REMARK 3 S21: -0.1351 S22: -0.0796 S23: 0.2984 REMARK 3 S31: 0.1075 S32: -0.2277 S33: 0.0039 REMARK 3 REMARK 3 TLS GROUP : 9 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 195 B 270 REMARK 3 ORIGIN FOR THE GROUP (A): -19.3750 11.2610 4.2830 REMARK 3 T TENSOR REMARK 3 T11: 0.6469 T22: 0.2421 REMARK 3 T33: 0.1399 T12: 0.0563 REMARK 3 T13: -0.1243 T23: 0.0005 REMARK 3 L TENSOR REMARK 3 L11: 7.3802 L22: 2.2238 REMARK 3 L33: 1.9946 L12: -3.3060 REMARK 3 L13: 3.6418 L23: -1.8703 REMARK 3 S TENSOR REMARK 3 S11: 0.1959 S12: 0.1054 S13: 0.0785 REMARK 3 S21: -0.3690 S22: -0.1094 S23: 0.0093 REMARK 3 S31: 0.4148 S32: 0.0318 S33: -0.0864 REMARK 3 REMARK 3 TLS GROUP : 10 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 271 B 347 REMARK 3 ORIGIN FOR THE GROUP (A): -7.5920 1.1000 17.1630 REMARK 3 T TENSOR REMARK 3 T11: 0.8586 T22: 0.2330 REMARK 3 T33: 0.1194 T12: -0.0227 REMARK 3 T13: -0.1100 T23: 0.0041 REMARK 3 L TENSOR REMARK 3 L11: 4.9430 L22: 2.9980 REMARK 3 L33: 0.6734 L12: -1.8585 REMARK 3 L13: 0.1507 L23: -0.2326 REMARK 3 S TENSOR REMARK 3 S11: -0.1337 S12: -0.2245 S13: -0.1965 REMARK 3 S21: -0.1326 S22: 0.2561 S23: -0.0852 REMARK 3 S31: 0.7261 S32: -0.1278 S33: -0.1224 REMARK 3 REMARK 3 TLS GROUP : 11 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 348 B 428 REMARK 3 ORIGIN FOR THE GROUP (A): -14.3410 21.8950 13.2370 REMARK 3 T TENSOR REMARK 3 T11: 0.2193 T22: 0.2104 REMARK 3 T33: 0.2344 T12: 0.0449 REMARK 3 T13: 0.0425 T23: -0.0188 REMARK 3 L TENSOR REMARK 3 L11: 5.8386 L22: 3.7799 REMARK 3 L33: 2.0792 L12: 0.8870 REMARK 3 L13: -0.1586 L23: -0.0297 REMARK 3 S TENSOR REMARK 3 S11: 0.2735 S12: -0.2630 S13: 0.3452 REMARK 3 S21: -0.2420 S22: -0.1191 S23: -0.4751 REMARK 3 S31: 0.1021 S32: 0.1641 S33: -0.1544 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2YNF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1290054481. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97872 REMARK 200 MONOCHROMATOR : DIAMOND LAUE MONOCHROMATORS REMARK 200 SUPPLIED BY JJ X-RAY REMARK 200 OPTICS : BERYLLIUM LENSES REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59250 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.45000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.150 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1HMV REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM HEPES PH7.5, 10MM SPERMIDINE, REMARK 280 1.1M SODIUM POTASSIUM TARTRATE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.51300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.51300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 59.78900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 77.25400 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 59.78900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 77.25400 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 78.51300 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 59.78900 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 77.25400 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 78.51300 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 59.78900 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 77.25400 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 43840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -2 REMARK 465 LYS A 65 REMARK 465 LYS A 66 REMARK 465 ASP A 67 REMARK 465 VAL A 559 REMARK 465 LEU A 560 REMARK 465 MET B -18 REMARK 465 ALA B -17 REMARK 465 GLY B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 GLY B -9 REMARK 465 SER B -8 REMARK 465 ALA B -7 REMARK 465 GLU B -6 REMARK 465 ASN B -5 REMARK 465 LEU B -4 REMARK 465 TYR B -3 REMARK 465 PHE B -2 REMARK 465 GLN B -1 REMARK 465 GLY B 0 REMARK 465 PRO B 1 REMARK 465 ILE B 2 REMARK 465 SER B 3 REMARK 465 PRO B 4 REMARK 465 ILE B 5 REMARK 465 PRO B 217 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 MET B 357 REMARK 465 ARG B 358 REMARK 465 GLY B 359 REMARK 465 ALA B 360 REMARK 465 HIS B 361 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A -1 CG OD1 ND2 REMARK 470 LYS A 49 CD CE NZ REMARK 470 GLU A 89 CG CD OE1 OE2 REMARK 470 LYS A 104 CG CD CE NZ REMARK 470 GLU A 138 CD OE1 OE2 REMARK 470 LYS A 173 CD CE NZ REMARK 470 ASP A 177 CG OD1 OD2 REMARK 470 GLU A 194 CG CD OE1 OE2 REMARK 470 ARG A 199 NE CZ NH1 NH2 REMARK 470 LYS A 219 CD CE NZ REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 LYS A 223 CE NZ REMARK 470 LYS A 249 CG CD CE NZ REMARK 470 ASP A 250 CG OD1 OD2 REMARK 470 LYS A 263 CE NZ REMARK 470 THR A 286 OG1 CG2 REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 GLU A 291 CG CD OE1 OE2 REMARK 470 GLN A 334 CG CD OE1 NE2 REMARK 470 GLU A 399 CG CD OE1 OE2 REMARK 470 GLU A 516 CD OE1 OE2 REMARK 470 LYS A 550 CG CD CE NZ REMARK 470 LYS A 558 CG CD CE NZ REMARK 470 GLU B 6 CG CD OE1 OE2 REMARK 470 LYS B 11 CD CE NZ REMARK 470 LYS B 13 CG CD CE NZ REMARK 470 MET B 16 CG SD CE REMARK 470 LYS B 22 CD CE NZ REMARK 470 LYS B 65 CG CD CE NZ REMARK 470 LYS B 66 CG CD CE NZ REMARK 470 ASP B 67 CG OD1 OD2 REMARK 470 LYS B 70 CG CD CE NZ REMARK 470 GLU B 122 CG CD OE1 OE2 REMARK 470 THR B 215 OG1 CG2 REMARK 470 LYS B 238 CG CD CE NZ REMARK 470 ASP B 250 CG OD1 OD2 REMARK 470 ARG B 277 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 281 CG CD CE NZ REMARK 470 GLU B 297 CG CD OE1 OE2 REMARK 470 GLU B 305 CG CD OE1 OE2 REMARK 470 GLU B 308 CG CD OE1 OE2 REMARK 470 GLU B 312 CG CD OE1 OE2 REMARK 470 LYS B 347 CD CE NZ REMARK 470 ARG B 356 CG CD NE CZ NH1 NH2 REMARK 470 THR B 419 OG1 CG2 REMARK 470 GLN B 428 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 460 O41 TAR A 1562 2.18 REMARK 500 O TYR B 232 O HOH B 2076 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A 315 CG HIS A 315 CD2 0.054 REMARK 500 TRP B 24 CE2 TRP B 24 CD2 0.083 REMARK 500 TRP B 229 CE2 TRP B 229 CD2 0.081 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 110 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 85 161.64 -48.69 REMARK 500 VAL A 90 -72.44 -71.88 REMARK 500 ASP A 121 128.91 -39.93 REMARK 500 ASN A 137 30.35 38.41 REMARK 500 MET A 184 -116.30 47.50 REMARK 500 TRP A 229 114.85 -164.12 REMARK 500 LYS A 249 128.63 -179.53 REMARK 500 ILE A 270 -24.43 -145.47 REMARK 500 GLN A 334 103.24 -52.84 REMARK 500 ALA A 355 83.33 -158.58 REMARK 500 PRO A 412 -178.58 -64.48 REMARK 500 ASP A 471 62.92 35.78 REMARK 500 ILE A 556 -53.77 -124.07 REMARK 500 PRO B 14 130.47 -39.79 REMARK 500 MET B 184 -121.43 54.61 REMARK 500 THR B 215 -175.60 -69.18 REMARK 500 VAL B 241 135.26 -38.76 REMARK 500 PHE B 346 -0.47 72.01 REMARK 500 LYS B 347 68.67 -104.36 REMARK 500 PRO B 421 -162.49 -78.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 PRESUMED MG IONS REMARK 600 D(-)-TARTARIC ACID (TAR): TARTRATE FROM CRYSTALLIZATION REMARK 600 CONDITION REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1559 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 443 OD1 REMARK 620 2 GLU A 478 OE2 60.9 REMARK 620 3 ASP A 498 OD1 88.8 72.5 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1560 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 443 OD2 REMARK 620 2 ASP A 498 OD2 107.7 REMARK 620 3 HOH A2235 O 130.9 90.4 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1559 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1560 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1561 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TAR A 1562 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WHU A 1563 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A30 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH A TRIPEPTIDE INHIBITOR REMARK 900 RELATED ID: 1BV7 RELATED DB: PDB REMARK 900 COUNTERACTING HIV-1 PROTEASE DRUG RESISTANCE: STRUCTURAL ANALYSIS REMARK 900 OF MUTANT PROTEASES COMPLEXED WITH XV638 AND SD146, CYCLIC UREA REMARK 900 AMIDES WITH BROAD SPECIFICITIES REMARK 900 RELATED ID: 1BV9 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (I84V) COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS REMARK 900 RELATED ID: 1BVE RELATED DB: PDB REMARK 900 HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR, 28 STRUCTURES REMARK 900 RELATED ID: 1BVG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE REMARK 900 STRUCTURE REMARK 900 RELATED ID: 1BWA RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH XV638 OF REMARK 900 DUPONT PHARMACEUTICALS REMARK 900 RELATED ID: 1BWB RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH SD146 OF REMARK 900 DUPONT PHARMACEUTICALS REMARK 900 RELATED ID: 1C0T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+ REMARK 900 21.1326 REMARK 900 RELATED ID: 1C0U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+ REMARK 900 50.0934 REMARK 900 RELATED ID: 1C1B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 GCA- 186 REMARK 900 RELATED ID: 1C1C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 TNK- 6123 REMARK 900 RELATED ID: 1DMP RELATED DB: PDB REMARK 900 STRUCTURE OF HIV-1 PROTEASE COMPLEX REMARK 900 RELATED ID: 1DTQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 PETT-1 (PETT131A94) REMARK 900 RELATED ID: 1DTT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 PETT-2 (PETT130A94) REMARK 900 RELATED ID: 1E6J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH REMARK 900 FAB13B5 REMARK 900 RELATED ID: 1EP4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S- REMARK 900 1153 REMARK 900 RELATED ID: 1ESK RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF NCP7 FROM HIV-1 REMARK 900 RELATED ID: 1EX4 RELATED DB: PDB REMARK 900 HIV-1 INTEGRASE CATALYTIC CORE AND C-TERMINAL DOMAIN REMARK 900 RELATED ID: 1EXQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIV-1 INTEGRASE CATALYTIC COREDOMAIN REMARK 900 RELATED ID: 1FB7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN IN VIVO HIV-1 PROTEASE MUTANT INCOMPLEX REMARK 900 WITH SAQUINAVIR: INSIGHTS INTO THE MECHANISMS OFDRUG RESISTANCE REMARK 900 RELATED ID: 1FK9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH DMP- REMARK 900 266(EFAVIRENZ) REMARK 900 RELATED ID: 1FKO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV- 1REVERSE REMARK 900 TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ ) REMARK 900 RELATED ID: 1FKP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV- 1REVERSE REMARK 900 TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1G6L RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF TETHERED HIV-1 PROTEASE REMARK 900 RELATED ID: 1HIV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WITH U75875 (NOA- HIS-CHA- REMARK 900 PSI[CH(OH)CH(OH)]VAL-ILE-APY) REMARK 900 RELATED ID: 1HVH RELATED DB: PDB REMARK 900 NONPEPTIDE CYCLIC CYANOGUANIDINES AS HIV PROTEASE INHIBITORS REMARK 900 RELATED ID: 1HVR RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) PROTEASE COMPLEXED WITH REMARK 900 XK263 OF DUPONT MERCK REMARK 900 RELATED ID: 1HWR RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS REMARK 900 RELATED ID: 1HXB RELATED DB: PDB REMARK 900 HIV-1 PROTEINASE COMPLEXED WITH RO 31-8959 REMARK 900 RELATED ID: 1JKH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH DMP-266(EFAVIRENZ) REMARK 900 RELATED ID: 1JLA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH TNK-651 REMARK 900 RELATED ID: 1JLB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1JLC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH PETT-2 REMARK 900 RELATED ID: 1JLE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSETRANSCRIPTASE REMARK 900 RELATED ID: 1JLF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1JLG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH UC-781 REMARK 900 RELATED ID: 1JLQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 739W94 REMARK 900 RELATED ID: 1KLM RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U- 90152 REMARK 900 RELATED ID: 1LV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE NON-ACTIVE SITE MUTANT OFTETHERED REMARK 900 HIV-1 PROTEASE TO 2.1A RESOLUTION REMARK 900 RELATED ID: 1LW0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1LW2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH 1051U91 REMARK 900 RELATED ID: 1LWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1LWE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSETRANSCRIPTASE REMARK 900 (RTMN) IN COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1LWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE(RTMQ+ REMARK 900 M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITHNEVIRAPINE REMARK 900 RELATED ID: 1NCP RELATED DB: PDB REMARK 900 RELATED ID: 1O1W RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE RNASE H DOMAIN OF THE HIV -1REVERSE REMARK 900 TRANSCRIPTASE IN THE PRESENCE OF MAGNESIUM REMARK 900 RELATED ID: 1ODW RELATED DB: PDB REMARK 900 NATIVE HIV-1 PROTEINASE REMARK 900 RELATED ID: 1ODY RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130 REMARK 900 RELATED ID: 1QBR RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1QBS RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1QBT RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1QBU RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1REV RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 1RT1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC- REMARK 900 442 REMARK 900 RELATED ID: 1RT2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK- REMARK 900 651 REMARK 900 RELATED ID: 1RT3 RELATED DB: PDB REMARK 900 AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH REMARK 900 1051U91 REMARK 900 RELATED ID: 1RT4 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781 REMARK 900 RELATED ID: 1RT5 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10 REMARK 900 RELATED ID: 1RT6 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38 REMARK 900 RELATED ID: 1RT7 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84 REMARK 900 RELATED ID: 1RTD RELATED DB: PDB REMARK 900 STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: REMARK 900 IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE REMARK 900 RELATED ID: 1RTH RELATED DB: PDB REMARK 900 RELATED ID: 1RTI RELATED DB: PDB REMARK 900 RELATED ID: 1RTJ RELATED DB: PDB REMARK 900 RELATED ID: 1S1T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH UC-781 REMARK 900 RELATED ID: 1S1U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1S1V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH TNK-651 REMARK 900 RELATED ID: 1S1W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH UC-781 REMARK 900 RELATED ID: 1S1X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1T05 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE- PRIMERWITH REMARK 900 TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMINGNUCLEOTIDE SUBSTRATE REMARK 900 RELATED ID: 1TAM RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS, NMR, MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1TKT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW426318 REMARK 900 RELATED ID: 1TKX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW490745 REMARK 900 RELATED ID: 1TKZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW429576 REMARK 900 RELATED ID: 1TL1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW451211 REMARK 900 RELATED ID: 1TL3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW450557 REMARK 900 RELATED ID: 1VRT RELATED DB: PDB REMARK 900 RELATED ID: 1VRU RELATED DB: PDB REMARK 900 RELATED ID: 2WHH RELATED DB: PDB REMARK 900 HIV-1 PROTEASE TETHERED DIMER Q-PRODUCT COMPLEX ALONG WITH REMARK 900 NUCLEOPHILIC WATER MOLECULE REMARK 900 RELATED ID: 2WOM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE REMARK 900 (K103N). REMARK 900 RELATED ID: 2WON RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE REMARK 900 (WILD-TYPE). REMARK 900 RELATED ID: 3PHV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (ISOLATE HXB2) REMARK 900 RELATED ID: 4B3O RELATED DB: PDB REMARK 900 STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT REMARK 900 CONFORMATION AND SUBSTRATE INTERFACE REMARK 900 RELATED ID: 4B3P RELATED DB: PDB REMARK 900 STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT REMARK 900 CONFORMATION AND SUBSTRATE INTERFACE REMARK 900 RELATED ID: 4B3Q RELATED DB: PDB REMARK 900 STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT REMARK 900 CONFORMATION AND SUBSTRATE INTERFACE REMARK 900 RELATED ID: 2YNG RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE MUTANT IN COMPLEX WITH INHIBITOR GSK560 REMARK 900 RELATED ID: 2YNH RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE MUTANT IN COMPLEX WITH INHIBITOR GSK500 REMARK 900 RELATED ID: 2YNI RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE MUTANT IN COMPLEX WITH INHIBITOR GSK952 REMARK 999 REMARK 999 SEQUENCE REMARK 999 Y188L MUTATION REMARK 999 POLY HIS TAG ADDED AT THE N-TERMINUS FOR PURIFICATION DBREF 2YNF A 1 560 UNP P04585 POL_HV1H2 588 1147 DBREF 2YNF B 1 428 UNP P04585 POL_HV1H2 588 1015 SEQADV 2YNF MET A -2 UNP P04585 EXPRESSION TAG SEQADV 2YNF ASN A -1 UNP P04585 EXPRESSION TAG SEQADV 2YNF SER A 0 UNP P04585 EXPRESSION TAG SEQADV 2YNF LEU A 188 UNP P04585 TYR 775 ENGINEERED MUTATION SEQADV 2YNF MET B -18 UNP P04585 EXPRESSION TAG SEQADV 2YNF ALA B -17 UNP P04585 EXPRESSION TAG SEQADV 2YNF GLY B -16 UNP P04585 EXPRESSION TAG SEQADV 2YNF HIS B -15 UNP P04585 EXPRESSION TAG SEQADV 2YNF HIS B -14 UNP P04585 EXPRESSION TAG SEQADV 2YNF HIS B -13 UNP P04585 EXPRESSION TAG SEQADV 2YNF HIS B -12 UNP P04585 EXPRESSION TAG SEQADV 2YNF HIS B -11 UNP P04585 EXPRESSION TAG SEQADV 2YNF HIS B -10 UNP P04585 EXPRESSION TAG SEQADV 2YNF GLY B -9 UNP P04585 EXPRESSION TAG SEQADV 2YNF SER B -8 UNP P04585 EXPRESSION TAG SEQADV 2YNF ALA B -7 UNP P04585 EXPRESSION TAG SEQADV 2YNF GLU B -6 UNP P04585 EXPRESSION TAG SEQADV 2YNF ASN B -5 UNP P04585 EXPRESSION TAG SEQADV 2YNF LEU B -4 UNP P04585 EXPRESSION TAG SEQADV 2YNF TYR B -3 UNP P04585 EXPRESSION TAG SEQADV 2YNF PHE B -2 UNP P04585 EXPRESSION TAG SEQADV 2YNF GLN B -1 UNP P04585 EXPRESSION TAG SEQADV 2YNF GLY B 0 UNP P04585 EXPRESSION TAG SEQRES 1 A 563 MET ASN SER PRO ILE SER PRO ILE GLU THR VAL PRO VAL SEQRES 2 A 563 LYS LEU LYS PRO GLY MET ASP GLY PRO LYS VAL LYS GLN SEQRES 3 A 563 TRP PRO LEU THR GLU GLU LYS ILE LYS ALA LEU VAL GLU SEQRES 4 A 563 ILE CYS THR GLU MET GLU LYS GLU GLY LYS ILE SER LYS SEQRES 5 A 563 ILE GLY PRO GLU ASN PRO TYR ASN THR PRO VAL PHE ALA SEQRES 6 A 563 ILE LYS LYS LYS ASP SER THR LYS TRP ARG LYS LEU VAL SEQRES 7 A 563 ASP PHE ARG GLU LEU ASN LYS ARG THR GLN ASP PHE TRP SEQRES 8 A 563 GLU VAL GLN LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS SEQRES 9 A 563 LYS LYS LYS SER VAL THR VAL LEU ASP VAL GLY ASP ALA SEQRES 10 A 563 TYR PHE SER VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR SEQRES 11 A 563 THR ALA PHE THR ILE PRO SER ILE ASN ASN GLU THR PRO SEQRES 12 A 563 GLY ILE ARG TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP SEQRES 13 A 563 LYS GLY SER PRO ALA ILE PHE GLN SER SER MET THR LYS SEQRES 14 A 563 ILE LEU GLU PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL SEQRES 15 A 563 ILE TYR GLN TYR MET ASP ASP LEU LEU VAL GLY SER ASP SEQRES 16 A 563 LEU GLU ILE GLY GLN HIS ARG THR LYS ILE GLU GLU LEU SEQRES 17 A 563 ARG GLN HIS LEU LEU ARG TRP GLY LEU THR THR PRO ASP SEQRES 18 A 563 LYS LYS HIS GLN LYS GLU PRO PRO PHE LEU TRP MET GLY SEQRES 19 A 563 TYR GLU LEU HIS PRO ASP LYS TRP THR VAL GLN PRO ILE SEQRES 20 A 563 VAL LEU PRO GLU LYS ASP SER TRP THR VAL ASN ASP ILE SEQRES 21 A 563 GLN LYS LEU VAL GLY LYS LEU ASN TRP ALA SER GLN ILE SEQRES 22 A 563 TYR PRO GLY ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU SEQRES 23 A 563 ARG GLY THR LYS ALA LEU THR GLU VAL ILE PRO LEU THR SEQRES 24 A 563 GLU GLU ALA GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE SEQRES 25 A 563 LEU LYS GLU PRO VAL HIS GLY VAL TYR TYR ASP PRO SER SEQRES 26 A 563 LYS ASP LEU ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY SEQRES 27 A 563 GLN TRP THR TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN SEQRES 28 A 563 LEU LYS THR GLY LYS TYR ALA ARG MET ARG GLY ALA HIS SEQRES 29 A 563 THR ASN ASP VAL LYS GLN LEU THR GLU ALA VAL GLN LYS SEQRES 30 A 563 ILE THR THR GLU SER ILE VAL ILE TRP GLY LYS THR PRO SEQRES 31 A 563 LYS PHE LYS LEU PRO ILE GLN LYS GLU THR TRP GLU THR SEQRES 32 A 563 TRP TRP THR GLU TYR TRP GLN ALA THR TRP ILE PRO GLU SEQRES 33 A 563 TRP GLU PHE VAL ASN THR PRO PRO LEU VAL LYS LEU TRP SEQRES 34 A 563 TYR GLN LEU GLU LYS GLU PRO ILE VAL GLY ALA GLU THR SEQRES 35 A 563 PHE TYR VAL ASP GLY ALA ALA ASN ARG GLU THR LYS LEU SEQRES 36 A 563 GLY LYS ALA GLY TYR VAL THR ASN ARG GLY ARG GLN LYS SEQRES 37 A 563 VAL VAL THR LEU THR ASP THR THR ASN GLN LYS THR GLU SEQRES 38 A 563 LEU GLN ALA ILE TYR LEU ALA LEU GLN ASP SER GLY LEU SEQRES 39 A 563 GLU VAL ASN ILE VAL THR ASP SER GLN TYR ALA LEU GLY SEQRES 40 A 563 ILE ILE GLN ALA GLN PRO ASP GLN SER GLU SER GLU LEU SEQRES 41 A 563 VAL ASN GLN ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS SEQRES 42 A 563 VAL TYR LEU ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY SEQRES 43 A 563 GLY ASN GLU GLN VAL ASP LYS LEU VAL SER ALA GLY ILE SEQRES 44 A 563 ARG LYS VAL LEU SEQRES 1 B 447 MET ALA GLY HIS HIS HIS HIS HIS HIS GLY SER ALA GLU SEQRES 2 B 447 ASN LEU TYR PHE GLN GLY PRO ILE SER PRO ILE GLU THR SEQRES 3 B 447 VAL PRO VAL LYS LEU LYS PRO GLY MET ASP GLY PRO LYS SEQRES 4 B 447 VAL LYS GLN TRP PRO LEU THR GLU GLU LYS ILE LYS ALA SEQRES 5 B 447 LEU VAL GLU ILE CYS THR GLU MET GLU LYS GLU GLY LYS SEQRES 6 B 447 ILE SER LYS ILE GLY PRO GLU ASN PRO TYR ASN THR PRO SEQRES 7 B 447 VAL PHE ALA ILE LYS LYS LYS ASP SER THR LYS TRP ARG SEQRES 8 B 447 LYS LEU VAL ASP PHE ARG GLU LEU ASN LYS ARG THR GLN SEQRES 9 B 447 ASP PHE TRP GLU VAL GLN LEU GLY ILE PRO HIS PRO ALA SEQRES 10 B 447 GLY LEU LYS LYS LYS LYS SER VAL THR VAL LEU ASP VAL SEQRES 11 B 447 GLY ASP ALA TYR PHE SER VAL PRO LEU ASP GLU ASP PHE SEQRES 12 B 447 ARG LYS TYR THR ALA PHE THR ILE PRO SER ILE ASN ASN SEQRES 13 B 447 GLU THR PRO GLY ILE ARG TYR GLN TYR ASN VAL LEU PRO SEQRES 14 B 447 GLN GLY TRP LYS GLY SER PRO ALA ILE PHE GLN SER SER SEQRES 15 B 447 MET THR LYS ILE LEU GLU PRO PHE ARG LYS GLN ASN PRO SEQRES 16 B 447 ASP ILE VAL ILE TYR GLN TYR MET ASP ASP LEU TYR VAL SEQRES 17 B 447 GLY SER ASP LEU GLU ILE GLY GLN HIS ARG THR LYS ILE SEQRES 18 B 447 GLU GLU LEU ARG GLN HIS LEU LEU ARG TRP GLY LEU THR SEQRES 19 B 447 THR PRO ASP LYS LYS HIS GLN LYS GLU PRO PRO PHE LEU SEQRES 20 B 447 TRP MET GLY TYR GLU LEU HIS PRO ASP LYS TRP THR VAL SEQRES 21 B 447 GLN PRO ILE VAL LEU PRO GLU LYS ASP SER TRP THR VAL SEQRES 22 B 447 ASN ASP ILE GLN LYS LEU VAL GLY LYS LEU ASN TRP ALA SEQRES 23 B 447 SER GLN ILE TYR PRO GLY ILE LYS VAL ARG GLN LEU CYS SEQRES 24 B 447 LYS LEU LEU ARG GLY THR LYS ALA LEU THR GLU VAL ILE SEQRES 25 B 447 PRO LEU THR GLU GLU ALA GLU LEU GLU LEU ALA GLU ASN SEQRES 26 B 447 ARG GLU ILE LEU LYS GLU PRO VAL HIS GLY VAL TYR TYR SEQRES 27 B 447 ASP PRO SER LYS ASP LEU ILE ALA GLU ILE GLN LYS GLN SEQRES 28 B 447 GLY GLN GLY GLN TRP THR TYR GLN ILE TYR GLN GLU PRO SEQRES 29 B 447 PHE LYS ASN LEU LYS THR GLY LYS TYR ALA ARG MET ARG SEQRES 30 B 447 GLY ALA HIS THR ASN ASP VAL LYS GLN LEU THR GLU ALA SEQRES 31 B 447 VAL GLN LYS ILE THR THR GLU SER ILE VAL ILE TRP GLY SEQRES 32 B 447 LYS THR PRO LYS PHE LYS LEU PRO ILE GLN LYS GLU THR SEQRES 33 B 447 TRP GLU THR TRP TRP THR GLU TYR TRP GLN ALA THR TRP SEQRES 34 B 447 ILE PRO GLU TRP GLU PHE VAL ASN THR PRO PRO LEU VAL SEQRES 35 B 447 LYS LEU TRP TYR GLN HET MG A1559 1 HET MG A1560 1 HET MG A1561 1 HET TAR A1562 10 HET WHU A1563 29 HETNAM MG MAGNESIUM ION HETNAM TAR D(-)-TARTARIC ACID HETNAM WHU 2-AZANYL-N-[[4-BROMANYL-3-(3-CHLORANYL-5-CYANO- HETNAM 2 WHU PHENOXY)-2-FLUORANYL-PHENYL]METHYL]-4-CHLORANYL-1H- HETNAM 3 WHU IMIDAZOLE-5-CARBOXAMIDE FORMUL 3 MG 3(MG 2+) FORMUL 6 TAR C4 H6 O6 FORMUL 7 WHU C18 H11 BR CL2 F N5 O2 FORMUL 8 HOH *434(H2 O) HELIX 1 1 THR A 27 GLU A 44 1 18 HELIX 2 2 PHE A 77 THR A 84 1 8 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 ALA A 114 VAL A 118 5 5 HELIX 5 5 ASP A 121 ALA A 129 5 9 HELIX 6 6 SER A 134 GLU A 138 5 5 HELIX 7 7 GLY A 155 ASN A 175 1 21 HELIX 8 8 GLU A 194 TRP A 212 1 19 HELIX 9 9 ASP A 218 GLN A 222 5 5 HELIX 10 10 THR A 253 SER A 268 1 16 HELIX 11 11 VAL A 276 LEU A 282 1 7 HELIX 12 12 THR A 296 GLU A 312 1 17 HELIX 13 13 ASN A 363 GLY A 384 1 22 HELIX 14 14 GLN A 394 TYR A 405 1 12 HELIX 15 15 THR A 473 SER A 489 1 17 HELIX 16 16 SER A 499 ALA A 508 1 10 HELIX 17 17 SER A 515 LYS A 528 1 14 HELIX 18 18 ILE A 542 ALA A 554 1 13 HELIX 19 19 THR B 27 GLU B 44 1 18 HELIX 20 20 PHE B 77 THR B 84 1 8 HELIX 21 21 THR B 84 VAL B 90 1 7 HELIX 22 22 GLY B 99 LYS B 103 5 5 HELIX 23 23 GLY B 112 VAL B 118 5 7 HELIX 24 24 ASP B 121 ALA B 129 5 9 HELIX 25 25 SER B 134 GLU B 138 5 5 HELIX 26 26 LYS B 154 ASN B 175 1 22 HELIX 27 27 GLU B 194 TRP B 212 1 19 HELIX 28 28 VAL B 254 TYR B 271 1 18 HELIX 29 29 VAL B 276 LEU B 283 1 8 HELIX 30 30 THR B 296 GLU B 312 1 17 HELIX 31 31 ASN B 363 GLY B 384 1 22 HELIX 32 32 GLN B 394 TRP B 402 1 9 HELIX 33 33 THR B 403 TYR B 405 5 3 HELIX 34 34 LEU B 422 GLN B 428 1 7 SHEET 1 AA 3 ILE A 47 ILE A 50 0 SHEET 2 AA 3 ILE A 142 TYR A 146 -1 O ARG A 143 N ILE A 50 SHEET 3 AA 3 PHE A 130 ILE A 132 -1 O PHE A 130 N TYR A 144 SHEET 1 AB 2 VAL A 60 ILE A 63 0 SHEET 2 AB 2 ARG A 72 VAL A 75 -1 O ARG A 72 N ILE A 63 SHEET 1 AC 3 SER A 105 ASP A 110 0 SHEET 2 AC 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 AC 3 VAL A 179 TYR A 183 -1 O VAL A 179 N GLY A 190 SHEET 1 AD 3 PHE A 227 TRP A 229 0 SHEET 2 AD 3 TYR A 232 LEU A 234 -1 O TYR A 232 N TRP A 229 SHEET 3 AD 3 TRP A 239 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 1 AE 5 ASN A 348 TYR A 354 0 SHEET 2 AE 5 GLN A 336 TYR A 342 -1 O TRP A 337 N TYR A 354 SHEET 3 AE 5 ILE A 326 GLY A 333 -1 O ILE A 326 N TYR A 342 SHEET 4 AE 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 AE 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 AF 2 HIS A 361 THR A 362 0 SHEET 2 AF 2 GLN A 512 SER A 513 -1 O GLN A 512 N THR A 362 SHEET 1 AG 5 GLN A 464 LEU A 469 0 SHEET 2 AG 5 GLY A 453 THR A 459 -1 O GLY A 453 N LEU A 469 SHEET 3 AG 5 GLU A 438 ALA A 446 -1 O TYR A 441 N VAL A 458 SHEET 4 AG 5 GLU A 492 THR A 497 1 O GLU A 492 N GLU A 438 SHEET 5 AG 5 LYS A 530 TRP A 535 1 O LYS A 530 N VAL A 493 SHEET 1 BA 3 ILE B 47 LYS B 49 0 SHEET 2 BA 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 BA 3 PHE B 130 ILE B 132 -1 O PHE B 130 N TYR B 144 SHEET 1 BB 2 VAL B 60 LYS B 64 0 SHEET 2 BB 2 TRP B 71 VAL B 75 -1 O ARG B 72 N ILE B 63 SHEET 1 BC 3 SER B 105 ASP B 110 0 SHEET 2 BC 3 ASP B 186 SER B 191 -1 O LEU B 187 N LEU B 109 SHEET 3 BC 3 VAL B 179 TYR B 183 -1 O VAL B 179 N GLY B 190 SHEET 1 BD 2 TRP B 252 THR B 253 0 SHEET 2 BD 2 VAL B 292 ILE B 293 -1 O ILE B 293 N TRP B 252 SHEET 1 BE 5 ASN B 348 ALA B 355 0 SHEET 2 BE 5 GLN B 336 TYR B 342 -1 O TRP B 337 N TYR B 354 SHEET 3 BE 5 ILE B 326 GLY B 333 -1 O ILE B 326 N TYR B 342 SHEET 4 BE 5 LYS B 388 LEU B 391 1 O LYS B 388 N ALA B 327 SHEET 5 BE 5 TRP B 414 PHE B 416 1 O GLU B 415 N LEU B 391 LINK OD1 ASP A 443 MG MG A1559 1555 1555 2.46 LINK OD2 ASP A 443 MG MG A1560 1555 1555 2.34 LINK O GLY A 444 MG MG A1561 1555 1555 2.51 LINK OE2BGLU A 478 MG MG A1559 1555 1555 2.51 LINK OD1 ASP A 498 MG MG A1559 1555 1555 2.65 LINK OD2 ASP A 498 MG MG A1560 1555 1555 2.68 LINK MG MG A1560 O HOH A2235 1555 1555 2.99 CISPEP 1 PRO A 225 PRO A 226 0 5.34 CISPEP 2 PRO A 345 PHE A 346 0 -0.61 CISPEP 3 PRO A 420 PRO A 421 0 3.44 SITE 1 AC1 5 ASP A 443 GLU A 478 ASP A 498 MG A1560 SITE 2 AC1 5 MG A1561 SITE 1 AC2 6 ASP A 443 ASP A 498 ASP A 549 ARG A 557 SITE 2 AC2 6 MG A1559 HOH A2235 SITE 1 AC3 5 ASP A 443 GLY A 444 GLU A 478 ARG A 557 SITE 2 AC3 5 MG A1559 SITE 1 AC4 8 ARG A 211 GLY A 436 ALA A 437 ASN A 460 SITE 2 AC4 8 ARG A 461 HOH A2239 ALA B 288 THR B 290 SITE 1 AC5 17 LEU A 100 LYS A 101 LYS A 102 LYS A 103 SITE 2 AC5 17 LYS A 104 SER A 105 VAL A 106 VAL A 108 SITE 3 AC5 17 VAL A 179 TYR A 181 LEU A 188 PHE A 227 SITE 4 AC5 17 TRP A 229 LEU A 234 HIS A 235 PRO A 236 SITE 5 AC5 17 TYR A 318 CRYST1 119.578 154.508 157.026 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008363 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006472 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006368 0.00000